Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have received an average rating of "Buy" from the five analysts that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $3.00.
Separately, Cormark upgraded shares of Cresco Labs from a "hold" rating to a "moderate buy" rating in a report on Monday, March 17th.
View Our Latest Research Report on Cresco Labs
Cresco Labs Price Performance
CRLBF stock traded down $0.02 during mid-day trading on Monday, reaching $0.69. The company's stock had a trading volume of 303,378 shares, compared to its average volume of 632,320. The stock has a market cap of $340.86 million, a PE ratio of -3.47 and a beta of 1.73. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a fifty-two week low of $0.52 and a fifty-two week high of $2.35. The company's 50 day moving average is $0.72 and its two-hundred day moving average is $0.92.
Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last posted its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $176.00 million during the quarter, compared to analysts' expectations of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. Equities research analysts expect that Cresco Labs will post -0.2 EPS for the current year.
Cresco Labs Company Profile
(
Get Free ReportCresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Articles

Before you consider Cresco Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.
While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.